{"href":"http://player.captivate.fm/services/oembed?url=http%3A%2F%2Fplayer.captivate.fm%2Fepisode%2Ff6dfe70d-8f32-4796-aaf1-8f7e06b883b2","version":"1.0","provider_name":"Captivate.FM","provider_url":"https://www.captivate.fm","width":600,"height":200,"type":"rich","html":"<iframe style=\"width: 100%; height: 200px;\" title=\"Joseph Birkett, Executive Director at Aura Biosciences \u2013 Obinutuzumab's Approval, CDK9 Trial Regret, CRO Reliance, and Building Respectful Cultures\" frameborder=\"0\" scrolling=\"no\" allow=\"clipboard-write\" seamless src=\"http://player.captivate.fm/episode/f6dfe70d-8f32-4796-aaf1-8f7e06b883b2\"></iframe>","title":"Joseph Birkett, Executive Director at Aura Biosciences \u2013 Obinutuzumab's Approval, CDK9 Trial Regret, CRO Reliance, and Building Respectful Cultures","description":"","thumbnail_width":300,"thumbnail_height":300,"thumbnail_url":"https://artwork.captivate.fm/e9804af5-2ff8-41d4-88c1-0847c6879ad9/bkgYzB9IUriVtzBthMNvd0jg.png"}